DENTSPLY SIRONA's fair value estimate has seen a modest decrease, from $16.21 to $16.00 per share. This reflects recent market reassessments. In addition, the stock's discount rate rose slightly, ...

An update from DENTSPLY SIRONA ( ($XRAY) ) is now available. On December 24, 2025, Dentsply Sirona amended its revolving credit facility and ...

CEO Simon Campion reported that Dentsply Sirona achieved organic growth in two out of three global regions during Q1 2025. Imaging and Wellspect Healthcare performed strongly, with imaging showing ...

Throughout the last three months, 5 analysts have evaluated Dentsply Sirona (NASDAQ:XRAY), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...

Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 13.4% in the morning session after it reported disappointing third-quarter results, highlighted by a significant earnings miss and ...

Management reaffirmed the full-year 2025 guidance for organic sales to decline by 2%-4% and adjusted EPS to remain in the range of $1.80 to $2. Reported sales guidance was revised upward to $3.6 ...